These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma. Kaplinsky C; Toren A; Neumann Y; Mandel M; Kenet G; Sharon N; Rechavi G; Biniaminov M; Rubanov V; Rosenthal E; Rosner E; Mark Z; Amariglio N; Brok-Simoni F Med Pediatr Oncol; 1997 Feb; 28(2):132-5. PubMed ID: 8986149 [TBL] [Abstract][Full Text] [Related]
23. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Carbone A; Gloghini A; Volpe R Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):527-32. PubMed ID: 1376944 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers. Khalidi HS; Singleton TP; Weiss SW Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Carbone A; Gloghini A; Volpe R Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287 [TBL] [Abstract][Full Text] [Related]
26. Ki-1-positive anaplastic large cell lymphoma initially diagnosed as Hodgkin's disease by fine needle aspiration (FNA) cytology. Aljajeh IA; Das DK; Krajci D Cytopathology; 1995 Aug; 6(4):226-35. PubMed ID: 8520002 [TBL] [Abstract][Full Text] [Related]
27. Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy? Vermeer MH; Bekkenk MW; Willemze R J Am Acad Dermatol; 2001 Oct; 45(4):638-40. PubMed ID: 11568767 [No Abstract] [Full Text] [Related]
29. Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol. Sekimizu M; Iguchi A; Mori T; Koga Y; Kada A; Saito AM; Horibe K BMC Cancer; 2018 Feb; 18(1):122. PubMed ID: 29390984 [TBL] [Abstract][Full Text] [Related]
30. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mohrmann RL; Arber DA Mod Pathol; 2000 Nov; 13(11):1244-52. PubMed ID: 11106083 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535 [TBL] [Abstract][Full Text] [Related]
32. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity. Barakzai MA; Pervez S Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769 [TBL] [Abstract][Full Text] [Related]
33. Ki-1-positive anaplastic large cell lymphoma with different phenotypes in skin nodules and lymph nodes. Oka K; Matsumoto T Dermatology; 1994; 188(1):52-6. PubMed ID: 8305759 [TBL] [Abstract][Full Text] [Related]
34. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553 [TBL] [Abstract][Full Text] [Related]
35. Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. Abbondanzo SL; Sato N; Straus SE; Jaffe ES Am J Clin Pathol; 1990 May; 93(5):698-702. PubMed ID: 2158227 [TBL] [Abstract][Full Text] [Related]
36. Case report: primary CD30 (Ki-1)-positive anaplastic large cell lymphoma of the duodenum. Yoshikawa I; Murata I; Tanaka Y; Kanagawa K; Tabaru A; Itoh H; Otsuki M Dig Dis Sci; 1996 Dec; 41(12):2343-7. PubMed ID: 9011440 [TBL] [Abstract][Full Text] [Related]
37. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment. Rinaldi I Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis of ALK-positive anaplastic large cell lymphoma based on CD30 testing. Gascoyne RD Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 2):3-6. PubMed ID: 24852617 [No Abstract] [Full Text] [Related]
39. Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease. Jansen MP; Machiels BM; Hopman AH; Broers JL; Bot FJ; Arends JW; Ramaekers FC; Schouten HC Histopathology; 1997 Oct; 31(4):304-12. PubMed ID: 9363444 [TBL] [Abstract][Full Text] [Related]
40. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]